524572
PHARMAID
Start SIP
Invest Now
Start SIP in PHARMAID
Performance
- Low
- ₹47
- High
- ₹49
- 52 Week Low
- ₹42
- 52 Week High
- ₹85
- Open Price₹49
- Previous Close₹49
- Volume3,111
Investment Returns
- Over 1 Month + 2.22%
- Over 3 Month -22.93%
- Over 6 Month -18.28%
- Over 1 Year -26.49%
Smart Investing Starts Here Start SIP with Pharmaids Pharmaceuticals for Steady Growth!
Pharmaids Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -12.5
- PEG Ratio
- 1.2
- Market Cap Cr
- 166
- P/B Ratio
- 3.2
- Average True Range
- 3.51
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 0.15
- RSI
- 48.53
- MFI
- 41.99
Pharmaids Pharmaceuticals Financials
Pharmaids Pharmaceuticals Technicals
EMA & SMA
Current Price
₹47.00
-1.74
(-3.57%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹49.20
- 50 Day
- ₹50.02
- 100 Day
- ₹52.80
- 200 Day
- ₹55.84
Resistance and Support
49.52
- R3 54.78
- R2 53.29
- R1 51.01
- S1 47.24
- S2 45.75
- S3 43.47
Pharmaids Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-11 | Quarterly Results | |
| 2025-08-07 | Quarterly Results | |
| 2025-05-23 | Audited Results | |
| 2025-02-12 | Quarterly Results | |
| 2024-11-13 | Quarterly Results |
Pharmaids Pharmaceuticals F&O
About Pharmaids Pharmaceuticals
- NSE Symbol
- PHARMAID
- BSE Symbol
- 524572
- ISIN
- INE117D01018
Similar Stocks to Pharmaids Pharmaceuticals
Pharmaids Pharmaceuticals FAQs
Pharmaids Pharmaceuticals share price is ₹47 As on 29 December, 2025 | 16:56
The Market Cap of Pharmaids Pharmaceuticals is ₹165.8 Cr As on 29 December, 2025 | 16:56
The P/E ratio of Pharmaids Pharmaceuticals is -12.5 As on 29 December, 2025 | 16:56
The PB ratio of Pharmaids Pharmaceuticals is 3.2 As on 29 December, 2025 | 16:56
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.